138 related articles for article (PubMed ID: 17032896)
21. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
22. A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.
Clarke LD; Plevritis SK; Boer R; Cronin KA; Feuer EJ
J Natl Cancer Inst Monogr; 2006; (36):96-105. PubMed ID: 17032899
[TBL] [Abstract][Full Text] [Related]
23. Competing risks to breast cancer mortality.
Rosenberg MA
J Natl Cancer Inst Monogr; 2006; (36):15-9. PubMed ID: 17032889
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer.
Burke JP; Power C; Gorey TF; Flanagan F; Kerin MJ; Kell MR
Eur J Surg Oncol; 2008 Feb; 34(2):149-53. PubMed ID: 17498912
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
[TBL] [Abstract][Full Text] [Related]
26. Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme.
Brown SB; Morrison DS; Cooke TG
Breast Cancer Res Treat; 2009 Aug; 116(3):603-7. PubMed ID: 18855136
[TBL] [Abstract][Full Text] [Related]
27. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis.
El Saghir NS; Khalil MK; Eid T; El Kinge AR; Charafeddine M; Geara F; Seoud M; Shamseddine AI
Int J Surg; 2007 Aug; 5(4):225-33. PubMed ID: 17660128
[TBL] [Abstract][Full Text] [Related]
28. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
[TBL] [Abstract][Full Text] [Related]
29. Predicting impacts of mass-screening policy changes on breast cancer mortality.
Seppänen J; Heinävaara S; Hakulinen T
Stat Med; 2008 Nov; 27(25):5235-51. PubMed ID: 18613224
[TBL] [Abstract][Full Text] [Related]
30. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
[TBL] [Abstract][Full Text] [Related]
31. Inequalities in breast cancer stage at diagnosis in the Trent region, and implications for the NHS Breast Screening Programme.
Cuthbertson SA; Goyder EC; Poole J
J Public Health (Oxf); 2009 Sep; 31(3):398-405. PubMed ID: 19423544
[TBL] [Abstract][Full Text] [Related]
32. A comparative review of thermography as a breast cancer screening technique.
Kennedy DA; Lee T; Seely D
Integr Cancer Ther; 2009 Mar; 8(1):9-16. PubMed ID: 19223370
[TBL] [Abstract][Full Text] [Related]
33. Forecasting age-specific breast cancer mortality using functional data models.
Erbas B; Hyndman RJ; Gertig DM
Stat Med; 2007 Jan; 26(2):458-70. PubMed ID: 16217849
[TBL] [Abstract][Full Text] [Related]
34. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
[TBL] [Abstract][Full Text] [Related]
35. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Paci E; Ponti A; Crocetti E; Zappa M; Segnan N
J Natl Cancer Inst; 2005 Dec; 97(24):1853-4; author reply 1854. PubMed ID: 16368949
[No Abstract] [Full Text] [Related]
36. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival.
Jensen AR; Madsen AH; Overgaard J
Acta Oncol; 2008; 47(4):537-44. PubMed ID: 18465319
[TBL] [Abstract][Full Text] [Related]
37. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the impact of breast cancer screening in South Australia.
Tallis GM; O'Neill TJ
Intern Med J; 2009 Mar; 39(3):174-8. PubMed ID: 19383066
[TBL] [Abstract][Full Text] [Related]
39. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
40. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
